Objectives: Lactate clearance has been widely investigated for its prognostic value in critically ill patients. However, the results are conflicting. The present study aimed to explore the diagnostic accuracy of lactate clearance in predicting mortality in critically or acutely ill patients. Data Sources: Databases of Medline, Embase, Scopus, and Web of Knowledge were searched from inception to June 2013. Study Selection: Studies investigating the prognostic value of lactate clearance were defined as eligible. The searched item consisted of terms related to critically ill patients and terms related to lactate clearance. Data Extraction: The following data were extracted: the name of the first author, publication year, subjects and setting, mean age of study population, sample size, male percentage, mortality of study cohort, definition of clearance, and the initial lactate level. Relative risk was reported to estimate the predictive value of lactate clearance on mortality rate, with relative risk less than 1 indicating that lactate clearance was a protective factor. Meta-analysis of diagnostic accuracy of lactate clearance in predicting mortality was performed by using hierarchical summary receiver operating characteristic model. Data Synthesis: A total of 15 original articles were included in the study. Because of the significant heterogeneity across studies (I 2 = 61.4%), random-effects model was used to pool relative risks. The pooled relative risk for mortality was 0.38 (95% CI, 0.29-0.50). The overall sensitivity and specificity for lactate clearance to predict mortality were 0.75 (95% CI, 0.58-0.87) and 0.72 (95% CI, 0.61-0.80), respectively. The diagnostic performance improved slightly when meta-analysis was restricted to ICU patients, with sensitivity and specificity of 0.83 (95% CI, 0.67-0.92) and 0.67 (95% CI, 0.59-0.75), respectively. Conclusion: Our study demonstrates that lactate clearance is predictive of lower mortality rate in critically ill patients, and its diagnostic performance is optimal for clinical utility. (Crit Care Med 2014; 42:2118-2125 
L actate in human body is produced from the reduction of pyruvate by the enzyme lactate dehydrogenase (1, 2) . In normal physiologic state, the reaction does not favor lactate formation, and this pathway only accounts for one tenth of the total pyruvate metabolism (3) . In a normal adult, a total amount of 1,500 mmol of lactate is produced daily and blood lactate levels are maintained less than 2 mmol/L. However, in critically ill conditions with hypoperfusion and hypoxia, pyruvate is accumulated rapidly and its metabolism is almost entirely shifted to lactate production (4, 5) . As a result, intracellular lactate increases exponentially and it will then be excreted into bloodstream. Both experimental and clinical studies confirm the tissue hypoxia, characterized as supply-dependent oxygen consumption, as a cause of lactate elevation (6, 7) .
Single lactate level, particularly those measured on ICU entry or arrival at emergency department (ED), is thought to be a strong predictor of subsequent organ dysfunction and mortality. Trzeciak et al (8) showed that an initial lactate level of more than 4 mmol/L was associated with substantial increases in the probability of acute-phase death. The predictive value of initial lactate has been confirmed in several large cohort or database studies (9) (10) (11) . However, single measurement of lactate is a static variable and can only serve as a risk-stratification biomarker. To make it more clinically useful, its trend, known as "lactate clearance" (LC), during treatment should be explored and its association with clinical outcome need to be Dr. Zhang conceived the idea and drafted the article; Dr. Xu helped collect data and interpreted the results. Dr. Zhang is the guarantor of the article, taking responsibility for the integrity of the work as a whole, from inception to published article.
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defined. More recently, many studies in critical care literature have investigated the role of LC in predicting outcomes, but the results are conflicting. To better define the accuracy of LC in predicting mortality in critically ill patients, we performed this systematic review with the hypothesis that LC was of good prognostic performance in predicting mortality.
METHODS

Searching Strategy and Study Selection
We searched databases of PubMed, EBSCO, Scopus, and ISI Web of Knowledge from inception to June 2013. The searched item consisted of terms related to critically ill patients (including intensive care unit, critical care, ICU, and critically ill) and terms related to LC (Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww.com/CCM/A973). There was no language restriction on searching. The study protocol was registered in PROSPERO (CRD42013006511) in November 2013. The study was approved by the institutional review board of Jinhua municipal central hospital.
Study selection consisted of three phases. Phase I involved the screening for titles and abstracts; phase II included reviewing of the full text of studies obtained by phase I; and phase III was to manually review the references of included studies to further identify potentially relevant studies. Studies investigating the prognostic accuracy of LC in predicting mortality in critically ill patients were thought to be relevant. Exclusion criteria were 1) trials involving neonates or pediatric patients; 2) studies reporting exogenous LC; 3) data on mortality could not be obtained even after contacting with the authors; and 4) LC was not investigated. Two reviewers independently performed searching strategy, and disagreement was settled by a third opinion at the conclusion of each phase.
Following data were abstracted from original articles in a standardized form: the name of the first author, publication year, subjects and setting, mean age of study population, sample size, male percentage, mortality of study cohort, definition of clearance, and the initial lactate level. Data used for metaanalysis were as follows: the numbers of survivors and nonsurvivors in LC and non-LC groups; area under receiver operating characteristics curve and corresponding CI; and cutoff value of LC for the best sensitivity and specificity. The cutoff value for LC was different across studies. To account for this heterogeneity, we used random-effects model for data synthesis. If these data were unavailable in original articles, we tried to contact the corresponding authors for more detailed information.
Quality Assessment
Newcastle Ottawa Scale for cohort study was used to assess the reporting quality of included component studies (12) . This scale comprises eight items evaluating the quality of observational cohort studies in terms of selection, comparability, and outcome. If patients were not followed up for the entire length of stay in hospital (e.g., ICU mortality), the follow-up was thought to be not long enough for the outcome to occur.
Statistical Analysis
Relative risk (RR) was reported to estimate the predictive value of LC on mortality rate. RR and its relevant 95% CI were pooled by using fixed-effect or random-effect models (the DerSimonian and Laird method) (13) . RR less than 1 indicated beneficial effect of the exposure for mortality. Heterogeneity was evaluated by using Q-test and I 2 index. I 2 less than 50% indicated a lack of heterogeneity among the studies, and the pooled RR was calculated by the fixed-effect model. Otherwise, the random-effect model was used. Sensitivity analysis was performed by excluding studies conducted in pediatric patients. Funnel plot was used for the assessment of publication bias, in which the SE of log (RR) of each study was plotted against its log (RR). Publication bias was tested using the method of Egger linear regression test (14) . An asymmetrical plot suggested a possible publication bias. Meta-analysis of diagnostic accuracy of LC in predicting mortality was performed. Between-study variation was expected to be significant due to the heterogeneity of definition of LC, patients and disease cohorts, study settings, and reference standards. Therefore, a hierarchical regression model for meta-analysis of studies reporting diagnostic accuracy (hierarchical summary receiver operating characteristic, see reference [15] for more details about this technique) was adopted, which allowed for more between-and within-study variability than other fixed-effect approaches. Pooled effect sizes for diagnostic performance including diagnostic odds ratio, sensitivity, specificity, positive likelihood ratio (LR+), and negative likelihood ratio (LR-) were reported. All statistical analyses were performed using Stata 11.2 (StataCorp, College Station, TX). Conventional two-tailed p less than 0.05 was considered statistically significant. Figure 1 shows the flowchart of study selection. The initial search identified 54 citations from Pubmed, 51 from EBSCO, 192 from ISI web of knowledge, and 79 from Scopus. Three hundred fiftyfour were excluded by inspection of titles and/or abstract. Fulltext articles were obtained for the remaining 22 citations. Seven of the 22 articles were excluded because three did not report LC; one included neonates; one used duplicated cohort; one did not provide mortality data even after contacting the author; one reported exogenous LC. As a result, a total of 15 citations (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) were included in the final analysis. The interobserver variability for data abstraction was small (κ = 0.93).
RESULTS
Study Selection and Characteristics
Characteristics of included studies are shown in Table 1 . Three studies (20, 21, 26) were randomized controlled trials. Five studies (17, 23, 25, 27, 30) included subjects with sepsis or septic shock; one (16) included injured patients. With respect to clinical setting, nine studies (16, 18, 19, (22) (23) (24) (28) (29) (30) were conducted in ICU and three (17, 25, 27) were performed in ED. All studies included patients aged between 50 and 70 years old, except for the study by Abramson et al (16) where the mean age was 35.5 years. There were more male patients than female patients in most studies, but the study by Arnold et al (17) enrolled equal number of males and females. The overall mortality varied across studies, ranging from 7.2% to 72.5%. Sample sizes of included studies were relatively small for observational studies (≤ 222 subjects). Definitions of LC varied across different studies. Most studies defined LC as the relative reduction in serum lactate levels within 6 hours. However, the magnitude of reduction varied across studies, ranging from 10% to 50%. Five studies (16, 19, 23, 24, 29) used 24 hours as the time frame to define LC. All studies reported that the initial lactate was elevated. The highest initial lactate was 8.3 mmol/L in the study by Wu et al (29) . Quality assessment was performed by using Newcastle Ottawa Scale for observational studies ( Table 2) . Table 3 displays the quality assessment for randomized controlled trials. The result showed that three studies scored 9 points, two scored 6 points, and the remaining scored between 6 and 9 points. Figure 2 shows the RR of death associated with LC. In sepsis, the RR for mortality was 0.41 (95% CI, 0.28-0.60). The heterogeneity was significantly reduced when subgroup analysis was restricted to ED patients (I 2 = 0, p = 0.483), and the RR was 0.41 (95% CI, 0.31-0.55). All included studies consistently showed that higher LC was associated with lower risk of death, with RR ranging from 0.04 to 0.57. Because of the significant heterogeneity across studies (I 2 = 61.4%), random-effects model was used to pool RRs. The meta-analysis showed that the pooled RR was 0.38 (95 CI% 0.29-0.50).
Diagnostic Performance of LC in Predicting Mortality
The pooled diagnostic performance of LC in predicting mortality is shown in Table 4 . Overall, the sensitivity and specificity were 0.75 (95% CI, 0.58-0.87) and 0.72 (95% CI, 0.61-0.80), respectively (Fig. 3) . The diagnostic performance improved slightly when meta-analysis was restricted to ICU patients, with sensitivity and specificity of 0.83 (95% CI, 0.67-0.92) and 0.67 (95% CI, 0.59-0.75), respectively. However, LC was of limited diagnostic value in patients with sepsis, with the sensitivity and specificity of 0.67 (95% CI, 0.38-0.87) and 0.73 (95% CI, 0.49-0.88). Contour-enhanced funnel plot is shown in Figure 4 . Several studies were in the area with the significance level of 0.01-0.05, suggesting that the asymmetry of the plot was not completely due to publication bias. Publication bias was considered to be absent by Egger test (p = 0.2).
DISCUSSION
The study shows that LC is strongly associated with all-cause mortality in critically ill patients. Rapid LC is a strong predictor of survival, and sustained elevation in lactate is a harbinger of adverse clinical outcome. Prognostic performance of LC was evaluated, and the result showed that LC is of moderate diagnostic performance in predicting mortality. Furthermore, in subgroup analysis, we found that the diagnostic value of LC improved slightly in ICU patients, and it is of limited value in patients with sepsis or septic shock. However, direct comparison between subgroups was not performed in the current analysis, and the subgroup population in whom LC has the great diagnostic performance needs to be validated in further studies.
LC is closely associated with capillary perfusion independent of hemodynamic variables, and it is thought to be a good biomarker of microcirculation (31) . Shock, irrespective of the causes, is characterized by disturbance in microcirculation, impaired oxygen delivery to tissues and organs, and finally the impairment of organ function (32, 33) . If not promptly reversed, sustained poor perfusion to vital organs will lead to multiple organ dysfunction syndrome that is well known to be a strong predictor of death. Early goal-directed therapy (EGDT) aims to reverse the pathological process by restoring circulation volume and oxygen delivery to tissue. Several trials have shown that protocolized, quantitative resuscitation aimed to achieve predefined LC can lead to improved clinical outcome compared with conventional bundles without incorporating LC (20, 34) . The 2012 sepsis guideline also suggests targeting resuscitation to normalize lactate in patients with elevated lactate (35) . Our study provides high-grade evidence to confirm the prognostic value of LC in critically ill patients. Our study is limited by the significant heterogeneity in component studies. Characteristics of component studies varied in terms of study population and settings, definition of LC, and initial lactate level. Heterogeneity was also confirmed statistically by an I 2 of 61.4%. We used random-effects model to pool effect sizes by assuming that individual studies are estimating different effect sizes (36) . Furthermore, subgroup analysis was performed to account for the heterogeneity. The result showed that the diagnostic performance of LC in predicting mortality was the best in ICU patients. However, in patients with sepsis or septic shock, LC was of limited value in predicting mortality (diagnostic odds ratio, 5.6; 95% CI, 3.0-10.4). By examining studies involving sepsis, we found that the measurements of serum lactate differed across studies. Some took the blood sample in ED, while others took the sample in ICU. EGDT dictates that the resuscitation goal should be achieved in the first 6 hours, beginning from the arrival to ED. Delayed resuscitation is associated with significantly increased risk of death (37, 38) . Although the resuscitation strategy was not explicitly addressed in these observational studies, the LC measured in different time points reflect the efficacy of resuscitation bundle in that time point. Thus, diagnostic performance of LC is significantly impaired due to the disparity in the measurement time. Cutoff values for LC are different among included component studies. LC is defined by the magnitude of lactate decrease and the time taken for the decrease. Some studies define the normalization of lactate as the cutoff value. The variability of the definition reflects the lack of consensus or standardized protocol for the measurement of lactate, which is an area of future investigation. Another confounding factor in our study is the use of renal replacement therapy that is effective in removing lactate from blood (39) . The effect may potentially mask the prognostic value of LC.
Our study has several clinical implications. First, persistently elevated serum lactate is a harbinger of adverse clinical 
A star (✩) was allocated to a particular item when it was adequately reported and addressed. The item "comparability" could be allocated with a maximum of two stars. Dashes indicate this item was not adequately reported or addressed. outcome, and this is helpful for risk stratification in critically ill patients. Second, since LC is strongly associated with mortality for critically ill patients, resuscitation bundles incorporating serum lactate as an endpoint are of clinical interest.
This intervention strategy has been tested in several pilot trials and the results are promising (20 output, and heart rate are normal. However, a great number of critically ill patients suffer from "cryptic" or "occult" shock, secondary to persistent cellular hypoperfusion. In our component studies, Liu et al (22) enrolled patients with paraquat poisoning whose serum lactate levels were significantly elevated but the mean blood pressure was within normal range. The risk of such population may be underestimated without measuring serum lactate. If resuscitation strategies aiming to normalize serum lactate levels are initiated immediately, the risk of death can be decreased. In aggregate, our study demonstrates that higher LC is predictive of lower mortality in critically ill patients, supporting the notion that resuscitation bundles involving LC may significantly improve patients' clinical outcome. Furthermore, the clinical value of LC is not restricted to patients with sepsis or septic shock, but it is of great usefulness in critically ill patients without evident circulatory shock. Elevated lactate is a harbinger of adverse clinical outcome, and its rapid clearance is universally associated with improved outcome in heterogeneous ICU or ED patient population. 
